Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine for Patients With Recurrent High Grade Glioma

NCT00293423 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00293423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00293423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine for Patients With Recurrent High Grade Glioma
Lead sponsor
University of California, San Francisco
Phase
Phase 1/2
Overall status
Completed
Start date
November 18, 2005
Completion date
January 12, 2013
Enrollment
96 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors